Clinical Trial: Single Dose Glumetinib in Healthy Chinese Male Subjects
Study Status: Completed
Recruit Status: Completed
Condition: Healthy Volunteers
Study Type: Interventional
Official Title: A Clinical Study to Evaluate Food Effect on Pharmacokinetics and Safety After Single Dose Glumetinib in Healthy Chinese Male Subjects
Brief Summary:
This is a phase I, single-center, randomized, open-label, single-dose, three-period (fasting, high-fat meal, low-fat meal) crossover clinical study to investigate the food effect on PK of the recommended phase II dose (RP2D) of 300 mg Glumetinib, based on the previous clinical studies of Glumetinib monotherapy.
Read more